The Precedent is an independent publication focused on regulatory accountability in the United States pharmaceutical and healthcare industry. We track enforcement actions, consent decrees, False Claims Act settlements, and ongoing litigation involving the country's largest pharmaceutical manufacturers, pharmacy benefit managers, and healthcare conglomerates.

Our editorial mission is simple: to make the enforcement record legible. Regulatory actions against major healthcare companies are often buried in federal registers, buried in legal filings, or reported briefly and then forgotten. We aggregate, contextualize, and score that record, so patients, policy professionals, journalists, and the public can understand what it means in aggregate.

The Precedent does not receive funding from the pharmaceutical industry, insurance companies, or their trade associations. We accept no advertising from any entity we cover. Our revenue comes from reader subscriptions and institutional licensing.

Editorial principles

Independence

No funding from covered industries. No advertising from entities we track.

Verifiability

Every enforcement action we cite links to a primary source: DOJ press releases, court dockets, consent orders, or SEC filings.

Proportionality

Our scoring methodology weights recent conduct more heavily than historical settlements. Companies can improve their standing.

Transparency

Our methodology is public. We publish our scoring criteria, data sources, and update schedule.